SCHEMBL29845257

SCHEMBL29845257

c1cc(C2CCNCC2)c2nc(C3CC3)[nH]c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 4/20 0.41
▸ PBK Q96KB5 3/20 0.40
▸ MAPK13 O15264 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ MAPK12 P53778 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ HTR6 P50406 2/20 0.37
▸ CDC7 O00311 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ CSNK2B P67870 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ CDK9 P50750 3/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ PRMT5 O14744 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683422 1.00 PARP1 (0.41) PARP1PBKMAPK13RAF1MAPK9
SCHEMBL29845323 0.91 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9
SCHEMBL29845331 0.91 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9
SCHEMBL24683415 0.91 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9
SCHEMBL30769737 0.90 PARP1 (0.43) PARP1PBKHTR6CDK9CDK1
SCHEMBL27035372 0.90 PARP1 (0.43) PARP1PBKHTR6CDK9CDK1
SCHEMBL27059733 0.90 PARP1 (0.43) PARP1PBKHTR6CDK9CDK1
Hydrochloric Acid SCHEMBL30769827 0.90 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9
Hydrochloric Acid SCHEMBL27035376 0.90 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9
Hydrochloric Acid SCHEMBL27147682 0.90 CDK9 (0.40) PARP1PBKMAPK13RAF1MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187518-A1 SUBSTITUTED 4-PIPERIDINYL-IMIDAZO[4,5-B]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Ikena Oncology, Inc. (US) 2022-09-09 — — WO disclosed
Send feedback